IDEXX > Companion Animal > Pet Food Recall: Monitoring/Resources
 

Pet Food Recall

resources


For more information about renal diseases and treatment please view the following resources:

 
April 24, 2007
View the archive >
Presentation Slides 2 MB
 
Answers to questions about diagnostic testing
 
Monitoring Guidelines
Frequently Asked Questions
Urine Sediment Evaluation Guidelines
Timeline of Events 75 KB
Pet Food Recall Home
cat

Additional Web sites:

Food and Drug Administration

American Veterinary Medical Association (AVMA)

American College of Veterinary Internal Medicine (ACVIM)

American Animal Hospital Association (AAHA)

American Association of Veterinary Laboratory Diagnosticians (AAVLD)

California Animal Health and Food Safety (CAHFS)

Upcoming issues of the Diagnostic Edge® newsletter will include additional information on management and monitoring of renal disease. Please sign up to receive Diagnostic Edge® communications.

back to the top

monitoring guidelines

Category
of Disease
Clinical Signs and Laboratory Results
Recheck Guidelines
Apparently unaffected No clinical signs, initial screening labwork normal, urine is concentrated without crystals or casts Recheck blood work* and urinalysis 3–4 weeks after last possible exposure to recalled pet food
Possible subclinical disease No clinical signs, normal renal values, but unconcentrated urine (Specific gravity ≤ 1.030 in dogs,
≤ 1.035 in cats)
Recheck bloodwork* and urinalysis in one week or sooner if clinical signs develop
Mild disease Mild azotemia, isosthenuria, casts and/or crystalluria Treat and recheck blood work* and urinalysis in 2–3 days
Severe disease Moderate to severe azotemia and isosthenuria Treat aggressively and recheck blood work* and urinalysis in 2–3 days or sooner based on clinical progression
 
Long-Term followup for all patients All affected animals should have long-term monitoring of renal parameters, even if initial azotemia and signs resolve with therapy. This may include re-evaluation of bloodwork* and urine 2–4 weeks following initial hospitalization and then every 3–6 months; or more frequently depending on severity of initial disease and persistence of azotemia.

*Blood work should ideally include a complete blood count (CBC) and chemistry panel (or renal panel) including electrolytes.

Please note: These monitoring recommendations are meant as a guideline only. Clinical discretion should be used with each patient based upon complete evaluation of the patient, including history, physical examination and laboratory data.

back to the top

This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe® Reader® software.

 
© 2008 IDEXX Laboratories, Inc.
All rights reserved.